Daniel Silman

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial

Pedro M. Folegatti, Mustapha Bittaye, Amy Flaxman et al. · The Lancet Infectious Diseases · 2020 · 236 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination

Angela M. Minassian, Sarah E. Silk, Jordan R. Barrett et al. · Med · 2021 · 167 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Prime and target immunization protects against liver-stage malaria in mice

Anita Gola, Daniel Silman, Adam A. Walters et al. · Science Translational Medicine · 2018 · 73 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Vaccines against Ebola virus

Navin Venkatraman, Daniel Silman, Pedro M. Folegatti et al. · Vaccine · 2017 · 52 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +10

Phase I assessments of first-in-human administration of a novel malaria anti-sporozoite vaccine candidate, R21 in matrix-M adjuvant, in UK and Burkinabe volunteers

Navin Venkatraman, Alfred B. Tiono, Georgina Bowyer et al. · medRxiv · 2019 · 28 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17